Extend Biosciences Inc.

Company Information

Company Name
Extend Biosciences Inc.
Address
1 Kendall Sq. Bldg. 200, Suite 2203
Cambridge, MA, 02139-
Phone
1 732-599-8580
URL
http://WWW.EXTENDBIO.COM
DUNS
963416420
Number of Employees
2
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
Y

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$987,950.00
4
SBIR Phase II
$499,999.00
1

Award List

  1. Enhancing the Pharmacokinetic Profile of Protein-based Drugs

    Amount: $99,999.00

    Many protein-based drugs have limited efficacy due to a short half-life or require intravenous delivery because of low bioavailability when given subcutaneously. Extend Biosciences is developing propr ...

    SBIR Phase I 2013 Department of Defense
  2. Monitor for Multiple Biomarkers for Detection of Alcohol Consumption

    Amount: $449,649.00

    DESCRIPTION (provided by applicant): Chronic alcohol consumption can cause progressive liver damage, resulting in steatohepatitis and cirrhosis, which can lead to other more fatal complications such a ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm

    Amount: $288,302.00

    DESCRIPTION (provided by applicant): Cachexia is a complex syndrome characterized by involuntary weight loss and skeletal muscle wasting that leads to fatigue, weakness and a loss of appetite that is ...

    SBIR Phase I 2013 Department of Health and Human Services
  4. SBIR Phase I: Carriers for Improved Drug Delivery of Biopharmaceuticals

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project will develop a platform technology that improves drug delivery. Many drugs, such as blood factors, require frequent dosing because they d ...

    SBIR Phase I 2013 National Science Foundation
  5. Enhancing the Pharmacokinetic Profile of Protein-based Drugs

    Amount: $499,999.00

    Many protein-based drugs have limited efficacy due to a short half-life or require intravenous delivery because of low bioavailability. Extend Biosciences is developing proprietary carrier molecules t ...

    SBIR Phase II 2014 Office for Chemical and Biological DefenseDepartment of Defense

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government